BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31493238)

  • 1. Impact of sustained virological response with DAAs on gastroesophageal varices and Baveno criteria in HCV-cirrhotic patients.
    Puigvehí M; Londoño MC; Torras X; Lorente S; Vergara M; Morillas RM; Masnou H; Serrano T; Miquel M; Gallego A; Lens S; Carrión JA
    J Gastroenterol; 2020 Feb; 55(2):205-216. PubMed ID: 31493238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy.
    Thabut D; Bureau C; Layese R; Bourcier V; Hammouche M; Cagnot C; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Goria O; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle-Bladou C; Dao T; Pilette C; Silvain C; Christidis C; Capron D; Bernard-Chabert B; Hillaire S; Di Martino V; Sutton A; Audureau E; Roudot-Thoraval F; Nahon P;
    Gastroenterology; 2019 Mar; 156(4):997-1009.e5. PubMed ID: 30768988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Course of oesophageal varices and performance of noninvasive predictors following Hepatitis C Virus clearance in compensated advanced chronic liver disease.
    Giannini EG; De Maria C; Crespi M; Demarzo MG; Fazio V; Grasso A; Torre F; Bodini G; Marabotto E; Furnari M
    Eur J Clin Invest; 2020 May; 50(5):e13231. PubMed ID: 32291753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baveno VI criteria and spleen stiffness measurement rule out high-risk varices in virally suppressed HBV-related cirrhosis.
    Wang H; Wen B; Chang X; Wu Q; Wen W; Zhou F; Guo Y; Ji Y; Gu Y; Lai Q; He Q; Li J; Chen J; Hou J
    J Hepatol; 2021 Mar; 74(3):584-592. PubMed ID: 33039403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening and surveillance of oesophageal varices in patients with HCV-positive liver cirrhosis successfully treated by direct-acting antiviral agents.
    Ciancio A; Ribaldone DG; Salamone R; Bruno M; Caronna S; Debernardi Venon W; Giordanino C; Mondardini A; Musso A; Pennazio M; Rolle E; Sacco M; Sprujevnik T; De Angelis C; Saracco GM
    Liver Int; 2022 May; 42(5):1121-1131. PubMed ID: 35220668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RESIST-HCV Criteria to Monitor Progression of Low-Risk Esophageal Varices in Patients With Compensated Cirrhosis After HCV Eradication: The SIMPLE Study: SIMPLE: Scoring Index to Monitor Progression of Low-risk Esophageal varices.
    Calvaruso V; Celsa C; D'Ambrosio R; Simone F; Petta S; Cacciola I; Enea M; Battaglia S; Pandolfo A; Licata M; Degasperi E; Cabibbo G; Di Marco L; Pennisi G; Borghi M; Di Martino V; Filomia R; Abdel-Hadi Y; Crapanzano L; Raimondo G; Lampertico P; Craxì A; Cammà C; Di Marco V
    Am J Gastroenterol; 2022 Nov; 117(11):1816-1824. PubMed ID: 35973181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver Stiffness-Based Strategies Predict Absence of Variceal Bleeding in Cirrhotic Hepatitis C Virus-Infected Patients With and Without Human Immunodeficiency Virus Coinfection After Sustained Virological Response.
    Corma-Gómez A; Macías J; Morano L; Rivero A; Téllez F; Ríos MJ; Santos M; Serrano M; Palacios R; Merino D; Real LM; De Los Santos I; Vera-Méndez FJ; Galindo MJ; Pineda JA;
    Clin Infect Dis; 2021 Mar; 72(5):e96-e102. PubMed ID: 33211801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of betablocked patients after sustained virological response in hepatitis C cirrhosis.
    Abadía M; Montes ML; Ponce D; Froilán C; Romero M; Poza J; Hernández T; Fernández-Martos R; Olveira A;
    World J Gastroenterol; 2019 Jun; 25(21):2665-2674. PubMed ID: 31210717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver stiffness regression after sustained virological response by direct-acting antivirals reduces the risk of outcomes.
    Piedade J; Pereira G; Guimarães L; Duarte J; Victor L; Baldin C; Inacio C; Santos R; Chaves Ú; Nunes EP; Grinsztejn B; Veloso VG; Fernandes F; Perazzo H
    Sci Rep; 2021 Jun; 11(1):11681. PubMed ID: 34083617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of original, expanded Baveno VI, and stepwise & platelet-MELD criteria to rule out varices needing treatment in compensated cirrhosis from various etiologies.
    Nawalerspanya S; Sripongpun P; Chamroonkul N; Kongkamol C; Piratvisuth T
    Ann Hepatol; 2020; 19(2):209-213. PubMed ID: 31607647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver Stiffness Measurement and Risk Prediction of Hepatocellular Carcinoma After HCV Eradication in Veterans With Cirrhosis.
    John BV; Dang Y; Kaplan DE; Jou JH; Taddei TH; Spector SA; Martin P; Bastaich DR; Chao HH; Dahman B
    Clin Gastroenterol Hepatol; 2024 Apr; 22(4):778-788.e7. PubMed ID: 38061410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive prediction of liver-related events in patients with HCV-associated compensated advanced chronic liver disease after oral antivirals.
    Pons M; Rodríguez-Tajes S; Esteban JI; Mariño Z; Vargas V; Lens S; Buti M; Augustin S; Forns X; Mínguez B; Genescà J
    J Hepatol; 2020 Mar; 72(3):472-480. PubMed ID: 31629779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression of liver fibrosis over a 24-week period after completing direct-acting antiviral therapy in patients with chronic hepatitis C receiving care within the national hepatitis C elimination program in Georgia: results of hepatology clinic HEPA experience.
    Dolmazashvili E; Abutidze A; Chkhartishvili N; Karchava M; Sharvadze L; Tsertsvadze T
    Eur J Gastroenterol Hepatol; 2017 Nov; 29(11):1223-1230. PubMed ID: 28857900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elastography is unable to exclude cirrhosis after sustained virological response in HCV-infected patients with advanced chronic liver disease.
    Broquetas T; Herruzo-Pino P; Mariño Z; Naranjo D; Vergara M; Morillas RM; Forns X; Carrión JA
    Liver Int; 2021 Nov; 41(11):2733-2746. PubMed ID: 34525253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baveno criteria perform better than expanded Baveno and Rete Sicilia Selezione Terapia-Hepatitis C virus criteria for predicting varices needing treatment.
    Agarwal A; Pathak P; Gupta S; Kumar R; Shalimar
    Indian J Gastroenterol; 2021 Dec; 40(6):590-597. PubMed ID: 33991311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the Baveno VI criteria to identify low risk cirrhotic patients not requiring endoscopic surveillance for varices.
    Maurice JB; Brodkin E; Arnold F; Navaratnam A; Paine H; Khawar S; Dhar A; Patch D; O'Beirne J; Mookerjee R; Pinzani M; Tsochatzis E; Westbrook RH
    J Hepatol; 2016 Nov; 65(5):899-905. PubMed ID: 27388923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variceal recurrence 4 years post endoscopic band ligation in hepatitis C patients who achieved sustained virological response with oral direct-acting antiviral therapy.
    Ibrahim ES; Abdel-Samiee M; Youssef MI; El-Shazly H; A El-Gendy AE; Sakr AA; Elwazzan D; Nassar MR; Aly Elshormilisy A; Madkour A; Kamal M; Amrousy YM; Elkhadry SW; Abdelsameea E
    J Viral Hepat; 2021 Feb; 28(2):279-287. PubMed ID: 33098209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Mac-2-binding protein glycosylation isomer predicts esophagogastric varices in cirrhotic patients with chronic hepatitis C virus infection treated with IFN-free direct-acting antiviral agent: M2BPGi levels predict varices in SVR patients.
    Kikukawa K; Uchida-Kobayashi S; Tamori A; Yoshida K; Kotani K; Motoyama H; Kozuka R; Hagihara A; Fujii H; Morikawa H; Enomoto M; Murakami Y; Kawada N
    Ann Hepatol; 2020; 19(4):367-372. PubMed ID: 32444247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic accuracy of Fibroscan for cirrhosis is influenced by liver morphometry in HCV patients with a sustained virological response.
    D'Ambrosio R; Aghemo A; Fraquelli M; Rumi MG; Donato MF; Paradis V; Bedossa P; Colombo M
    J Hepatol; 2013 Aug; 59(2):251-6. PubMed ID: 23528378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive assessment of liver fibrosis can predict clinical outcomes at late follow-up after a sustained virological response in HCV patients?
    Ragazzo TG; Zitelli PMY; Mazo DF; Oliveira CP; Carrilho FJ; Pessoa MG
    Clinics (Sao Paulo); 2024; 79():100381. PubMed ID: 38733689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.